» Authors » Ozden Hatirnaz Ng

Ozden Hatirnaz Ng

Explore the profile of Ozden Hatirnaz Ng including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 98
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Agaoglu N, Yalcin K, Unal B, Onder G, Celen S, Zhumatayev S, et al.
Cancer Genet . 2025 Feb; 292-293:120-123. PMID: 40020528
Germline pathogenic variants (PVs) in CBL are found in 15 % of juvenile myelomonocytic leukemia (JMML) cases. Here we report three siblings with CBL(NM_005188):c.1111T>C variation presenting a heterogenous JMML clinic...
2.
Erbilgin Y, Firtina S, Kirat E, Khodzhaev K, Karakas Z, Unuvar A, et al.
Biochem Genet . 2025 Jan; PMID: 39786526
IKZF1 deletions (ΔIKZF1) are common in precursor B-cell acute lymphoblastic leukemia (B-ALL) and are assumed to have a prognostic impact. We aimed to determine the prognostic implications of ΔIKZF1 and...
3.
Ozdemir O, Bychkovsky B, Unal B, Onder G, Amanvermez U, Aydin E, et al.
Cancers (Basel) . 2024 Nov; 16(22). PMID: 39594831
() is a tumor suppressor gene involved in DNA repair and cell cycle regulation. Pathogenic or likely pathogenic (P/LP) variants in are associated with increased cancer risk. Conversely, recent large...
4.
Bilgic-Eltan S, Amirov R, Babayeva R, Yorgun Altunbas M, Karakurt T, Can S, et al.
Scand J Immunol . 2024 Oct; 100(6):e13418. PMID: 39474990
Infants with congenital heart disease (CHD) often undergo thymectomy during corrective cardiac surgery (CCS). The long-term immunological effects remain controversial, with concerns regarding increased susceptibility to infections, allergies, autoimmunity due...
5.
Delgado-Vega A, Cederroth H, Taylan F, Ekholm K, Ek M, Thonberg H, et al.
Nat Genet . 2024 Oct; 56(11):2287-2294. PMID: 39433890
No abstract available.
6.
Agaoglu N, Ng O, Zemheri I, Unal B, Gerenli N, Tosun I, et al.
Am J Med Genet A . 2024 Oct; 197(2):e63897. PMID: 39392178
Germline pathogenic variants (PVs) in CDH1 cause hereditary diffuse gastric cancer. The management of CDH1 cases with a positive family history includes total prophylactic gastrectomy or intensive surveillance. In this...
7.
Guner Yilmaz B, Akgun-Dogan O, Ozdemir O, Yuksel B, Ng O, Bilguvar K, et al.
Front Pediatr . 2024 Jul; 12:1412880. PMID: 39026936
Introduction: Rare and ultra-rare genetic conditions significantly contribute to infant morbidity and mortality, often presenting with atypical features and genetic heterogeneity that complicate management. Rapid genome sequencing (RGS) offers a...
8.
Agaoglu N, Unal B, Hayes C, Walker M, Ng O, Doganay L, et al.
Cancer Med . 2024 Feb; 13(3):e6852. PMID: 38308423
Objective: Turkish genome is underrepresented in large genomic databases. This study aims to evaluate the effect of allele frequency in the Turkish population in determining the clinical utility of germline...
9.
Firtina S, Erbilgin Y, Ng O, Karaman S, Karakas Z, Celkan T, et al.
Scand J Clin Lab Invest . 2023 Apr; 83(3):187-193. PMID: 37029683
The () gene is one of the most studied genes in cancer. Although variants are rare events in acute leukemia, recent observations showed that relapse samples might harbor variants. Here,...
10.
Ng O, Sahin I, Erbilgin Y, Ozdemir O, Yucesan E, Erturk N, et al.
Front Public Health . 2023 Jan; 10:1049349. PMID: 36684907
Rare disease patients constitute a significant part of the healthcare system of all countries. However, the information on the experiences during disease processes and daily life of rare disease patients...